A Systematic Review and Meta-Analysis of the Association between the FV H1299R Variant and the Risk of Recurrent Pregnancy Loss
Open Access
Abstract
This study evaluated the association between the H1299R factor V (FV) variant (rs1800595) and recurrent pregnancy loss (RPL). Pubmed (MEDLINE) and Embase (OVID) bibliographic databases were searched from the inception to 31 May 2022 to identify suitable articles according to PRISMA and MOOSE guidelines. We included observational studies, case-control studies, cross-sectional studies, and cohort studies reporting a numerical and well-distinguished Het or Hom status of the H1299R variant obtained through PCR or other biochemical techniques and comparing RPL patients with a healthy control group. The review protocol was registered at PROSPERO (CRD42022330077). Two authors independently screened studies, extracted data, and carried out the risk of bias assessment using the Newcastle Ottawa scale (NOS). A meta-analysis was performed with RevMan software Version 5.4 using an odds ratio (OR) with an M-H, random effect, and 95% CI. We included 13 clinical studies for a total of 1669 RPL patients and 1466 healthy women as a control group. H1299R variant was slightly associated with RPL albeit without significance (OR 1.18, 95% CI: 0.78–1.80, p = 0.44). Subgroup analyses considering H1299R in heterozygosity (OR 1.13, 95% CI: 0.76–1.67, p = 0.56) and in homozygosity (OR: 2.11, 95% CI: 0.74–6.01, p = 0.16) revealed a similar trend. Lastly, we evaluated the association between H1299R and RPL based on the number of previous miscarriages (≥2 or ≥3). This comprehensive systematic review and meta-analysis sheds light on the specific influence of the H1299R variant in the F5 gene on RPL, constituting valid support for medical care during pregnancy and genetic counseling.Keywords
This publication has 34 references indexed in Scilit:
- Association Between Thrombophilic Gene Mutations and the Risk of Vascular Access Thrombosis in Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2016
- Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case–control study in Indian populationJournal of Thrombosis and Thrombolysis, 2015
- Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal associationArchives of Gynecology and Obstetrics, 2014
- The association between thrombophilic gene mutations and recurrent pregnancy lossJournal of Assisted Reproduction and Genetics, 2013
- Candidate gene study of genetic thrombophilic polymorphisms in pre‐eclampsia and recurrent pregnancy loss in Sinhalese womenJournal of Obstetrics and Gynaecology Research, 2012
- Combined Thrombophilic Mutations in Women with Unexplained Recurrent MiscarriageAmerican Journal of Reproductive Immunology, 2007
- Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese populationPathology, 2006
- Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence ReviewAmerican Journal of Epidemiology, 2004
- Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutationsBlood, 2004
- Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal lossThe Journal of Maternal-Fetal & Neonatal Medicine, 2002